Biogen secures extended access agreement for Spinraza
Biogen announces new data providing further evidence for SPINRAZA (nusinersen) as a treatment for SMA - Spinal News International
EMA opinion on broad-label approval for Spinraza – TreatSMA
Hydrocephalus a side effect of Spinraza? - SMA News Today Forums
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study - The Lancet
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Novartis' £1.79M gene therapy Zolgensma scores cost watchdog's backing, threatening Biogen's Spinraza | FiercePharma
First treatment for 5q spinal muscular atrophy approved by EU
Buy Spinraza (Nusinersen) Online • Price & Costs | TheSocialMedwork
Spinraza®: coverage for all SMA type 1,2,3 patients - Institut de Myologie
Spinraza™ represents the first FDA-approved drug for the treatment for... | Download Scientific Diagram
Spinraza - FDA prescribing information, side effects and uses
What is Spinraza? Uses, Side Effects & More | TheSocialMedwork
HSE approves Spinraza after lengthy campaign by patients
NHS to use world's most expensive drug to treat spinal muscular atrophy | NHS | The Guardian
From Idea to Injection: How Spinraza Came to Be - SMA News Today
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Biogen bounces back with Spinraza early treatment data - PMLiVE
Farmalisa - Spinraza is a medicine used to treat 5q spinal muscular atrophy (SMA), a genetic disease that causes weakness and wasting of the muscles including the lung muscles. The disease is
Biogen provides information on upcoming Spinraza EU label | SMA Europe
Spinraza (PF) intrathecal: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
U.S. FDA Approves Biogen's SPINRAZA™ (nusinersen), The First Treatment for Spinal Muscular Atrophy | Biogen
Biogen update on European access to Spinraza – TreatSMA
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
5. Spinraza | FiercePharma
NHS labels Spinraza deal “one of the most comprehensive in the world”
Biogen's blockbuster rare disease drug could be in trouble
Spinraza in the UK ‒ questions and answers – TreatSMA
